See All Slides - tctmd.com

Slides

Presentation NY Valves 2025

Two Deliveries in One Day: Cesarean Section Followed by an Immediate Valve-in-Valve TAVR in a Patient With Congenital Heart Disease and Bioprosthetic Valve Failure

Presenter: Faisal Alkhatib Tamimi

June 25, 2025

Presentation NY Valves 2025

Post-TTVR Function: Normal or Abnormal

Presenter: G. Burkhard Mackensen

June 25, 2025

Presentation NY Valves 2025

Clipping Strategies and Outcomes in Atrial SMR Patients Treated with the MitraClip System

Presenter: Mark J. Ricciardi

June 25, 2025

Presentation NY Valves 2025

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Presenter: Jörg Hausleiter

June 25, 2025

Presentation NY Valves 2025

Advanced Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the US

Presenter: Philippe Genereux

June 25, 2025

Presentation NY Valves 2025

The ABC Bicuspid Sizing Protocol for Sapien 3 Balloon Expandable Valves

Presenter: Tej Sheth

June 25, 2025

Presentation NY Valves 2025

Case Resolution: A Symptomatic Patient With Moderate to Severe MR

Presenter: Fahad Gilani

June 25, 2025

Presentation NY Valves 2025

How Do I Assess the Mechanism and Severity of MR After M-TEER?

Presenter: Federico M. Asch

June 25, 2025

Presentation NY Valves 2025

First Report of Successful TAVR in a Failed Prior Ozaki Aortic Valve Reconstruction

Presenter: Ahmed Ghoneem

June 25, 2025

Presentation NY Valves 2025

Outcomes of Patients 75 Years and Older With Bicuspid vs Tricuspid Aortic Valves Undergoing TAVR

Presenter: Tamari Lomaia

June 25, 2025

Advertisement

Slides

Two Deliveries in One Day: Cesarean Section Followed by an Immediate Valve-in-Valve TAVR in a Patient With Congenital Heart Disease and Bioprosthetic Valve Failure

Post-TTVR Function: Normal or Abnormal

Clipping Strategies and Outcomes in Atrial SMR Patients Treated with the MitraClip System

Optimizing Mitral TEER in FMR: Technical and Device Strategies

Advanced Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the US

The ABC Bicuspid Sizing Protocol for Sapien 3 Balloon Expandable Valves

Case Resolution: A Symptomatic Patient With Moderate to Severe MR

How Do I Assess the Mechanism and Severity of MR After M-TEER?

First Report of Successful TAVR in a Failed Prior Ozaki Aortic Valve Reconstruction

Outcomes of Patients 75 Years and Older With Bicuspid vs Tricuspid Aortic Valves Undergoing TAVR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content